{"id":60783,"date":"2026-06-04T23:21:33","date_gmt":"2026-06-04T14:21:33","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-130a\/"},"modified":"2026-07-26T14:54:50","modified_gmt":"2026-07-26T05:54:50","slug":"company-130a","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-130a\/","title":{"rendered":"VERITAS IN SILICO INC"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"130A","DATE":"2026-01-09","longName":"VERITAS IN SILICO INC","company_name_ja":"","fullTimeEmployees":19,"address":"","phone":"","website":"https:\/\/www.veritasinsilico.com","industry":"Biotechnology","sector":"Healthcare","regularMarketPrice":469,"financialCurrency":"","marketCap":3042,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":91140000,"OperatingIncome":-396748000,"operatingMargins":-435.31999999999999,"NetIncome":-425671000,"profitMargins":-467.05000000000001,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":-23.859999999999999,"recommendationMean":0,"recommendationKey":"none","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-07-01T04:48:09.327647\", \"ticker\": \"130A\", \"ticker_full\": \"130A.T\", \"company_name\": \"VERITAS IN SILICO INC\", \"analyst_recommendations\": {\"has_data\": true, \"recommendation_key\": \"none\", \"recommendation_mean\": null, \"total_analysts\": null, \"strong_buy\": null, \"buy\": null, \"hold\": null, \"sell\": null, \"strong_sell\": null}, \"target_prices\": {\"has_data\": true, \"current\": 430.0, \"high\": null, \"low\": null, \"mean\": null, \"median\": null}, \"earnings_dates\": {\"has_data\": false}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 50.2, \"institution_pct\": 14.18, \"major_holders\": [{\"label\": \"\", \"value\": 50.2}, {\"label\": \"\", \"value\": 14.18}, {\"label\": \"\", \"value\": 28.46}, {\"label\": \"\", \"value\": 3.0}], \"institutional_holders\": [], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Veritas In Silico Inc. engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA. The company has commercialization agreement with Liverpool ChiroChem for the mRNA-targeted drug discovery and development. Veritas In Silico Inc. was incorporated in 2016 and is based in Shinagawa, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-07-26T03:33:44.831053\", \"ticker\": \"130A\", \"ticker_full\": \"130A.T\", \"company_name\": \"VERITAS IN SILICO INC\", \"company_info\": {\"name_en\": \"VERITAS IN SILICO INC\", \"long_name\": \"\", \"sector\": \"Healthcare\", \"industry\": \"Biotechnology\", \"website\": \"https:\/\/www.veritasinsilico.com\", \"employees\": 19, \"country\": \"Japan\", \"city\": \"Shinagawa\", \"address\": \"1-11-1 Nishigotanda\", \"description\": \"Veritas In Silico Inc. engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA. The company has commercialization agreement with Liverpool ChiroChem for the mRNA-targeted drug discovery and development. Veritas In Silico Inc. was incorporated in 2016 and is based in Shinagawa, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 415.6, \"deviation\": 0.34, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 423.72, \"deviation\": -1.59, \"trend\": \"down\"}, \"ma_75\": {\"ma_value\": 435.57, \"deviation\": -4.26, \"trend\": \"down\"}, \"ma_200\": {\"ma_value\": 488.6, \"deviation\": -14.65, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 91140000.0, \"revenue_fmt\": \"\u00a591.1M\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -396748000.0, \"operating_income_fmt\": \"-\u00a54\u5104\", \"ebit\": -396748000.0, \"ebit_fmt\": \"-\u00a54\u5104\", \"net_income\": -425671000.0, \"net_income_fmt\": \"-\u00a54\u5104\", \"eps\": 0, \"operating_margin\": -435.32, \"total_assets\": 1884912000.0, \"total_assets_fmt\": \"\u00a519\u5104\", \"total_equity\": 1783876000.0, \"total_equity_fmt\": \"\u00a518\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 1825213000.0, \"total_cash_fmt\": \"\u00a518\u5104\", \"equity_ratio\": 94.64, \"de_ratio\": 0.0, \"current_ratio\": 18.46, \"operating_cf\": -299265000.0, \"operating_cf_fmt\": \"-\u00a53\u5104\", \"investing_cf\": 451119000.0, \"investing_cf_fmt\": \"\u00a55\u5104\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": -330507000.0, \"free_cf_fmt\": \"-\u00a53\u5104\", \"net_margin\": -467.05, \"roe\": -23.86, \"roa\": -22.58}, {\"year\": 2024, \"revenue\": 194643000.0, \"revenue_fmt\": \"\u00a52\u5104\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -212850000.0, \"operating_income_fmt\": \"-\u00a52\u5104\", \"ebit\": -212850000.0, \"ebit_fmt\": \"-\u00a52\u5104\", \"net_income\": -236442000.0, \"net_income_fmt\": \"-\u00a52\u5104\", \"eps\": -37.11, \"operating_margin\": -109.35, \"total_assets\": 2248958000.0, \"total_assets_fmt\": \"\u00a522\u5104\", \"total_equity\": 2209547000.0, \"total_equity_fmt\": \"\u00a522\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 2173358000.0, \"total_cash_fmt\": \"\u00a522\u5104\", \"equity_ratio\": 98.25, \"de_ratio\": 0.0, \"current_ratio\": 56.64, \"operating_cf\": -217944000.0, \"operating_cf_fmt\": \"-\u00a52\u5104\", \"investing_cf\": -2005988000.0, \"investing_cf_fmt\": \"-\u00a520\u5104\", \"financing_cf\": 848179000.0, \"financing_cf_fmt\": \"\u00a58\u5104\", \"free_cf\": -223646000.0, \"free_cf_fmt\": \"-\u00a52\u5104\", \"net_margin\": -121.47, \"roe\": -10.7, \"roa\": -10.51}, {\"year\": 2023, \"revenue\": 360356000.0, \"revenue_fmt\": \"\u00a54\u5104\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 37623000.0, \"operating_income_fmt\": \"\u00a537.6M\", \"ebit\": 37623000.0, \"ebit_fmt\": \"\u00a537.6M\", \"net_income\": 33048000.0, \"net_income_fmt\": \"\u00a533.0M\", \"eps\": 6.01, \"operating_margin\": 10.44, \"total_assets\": 1655531000.0, \"total_assets_fmt\": \"\u00a517\u5104\", \"total_equity\": 1575638000.0, \"total_equity_fmt\": \"\u00a516\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 1549111000.0, \"total_cash_fmt\": \"\u00a515\u5104\", \"equity_ratio\": 95.17, \"de_ratio\": 0.0, \"current_ratio\": 20.39, \"operating_cf\": 68710000.0, \"operating_cf_fmt\": \"\u00a568.7M\", \"investing_cf\": -2031000.0, \"investing_cf_fmt\": \"-\u00a52.0M\", \"financing_cf\": -2000000.0, \"financing_cf_fmt\": \"-\u00a52.0M\", \"free_cf\": 66679000.0, \"free_cf_fmt\": \"\u00a566.7M\", \"net_margin\": 9.17, \"roe\": 2.1, \"roa\": 2.0}, {\"year\": 2022, \"revenue\": 178801000.0, \"revenue_fmt\": \"\u00a52\u5104\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -138909000.0, \"operating_income_fmt\": \"-\u00a51\u5104\", \"ebit\": -138909000.0, \"ebit_fmt\": \"-\u00a51\u5104\", \"net_income\": -141381000.0, \"net_income_fmt\": \"-\u00a51\u5104\", \"eps\": -25.7, \"operating_margin\": -77.69, \"total_assets\": 1598576000.0, \"total_assets_fmt\": \"\u00a516\u5104\", \"total_equity\": 1542590000.0, \"total_equity_fmt\": \"\u00a515\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 1484432000.0, \"total_cash_fmt\": \"\u00a515\u5104\", \"equity_ratio\": 96.5, \"de_ratio\": 0.0, \"current_ratio\": 27.64, \"operating_cf\": -148780000.0, \"operating_cf_fmt\": \"-\u00a51\u5104\", \"investing_cf\": -55547000.0, \"investing_cf_fmt\": \"-\u00a555.5M\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": -204294000.0, \"free_cf_fmt\": \"-\u00a52\u5104\", \"net_margin\": -79.07, \"roe\": -9.17, \"roa\": -8.84}, {\"year\": 2021, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": -36.87, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}], \"has_data\": true}, \"dividends\": {\"history\": [], \"has_data\": false}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-60783","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>VERITAS IN SILICO INC - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-130a\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-130a\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-130a\/\",\"name\":\"VERITAS IN SILICO INC - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-04T14:21:33+00:00\",\"dateModified\":\"2026-07-26T05:54:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-130a\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-130a\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-130a\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VERITAS IN SILICO INC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VERITAS IN SILICO INC - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-130a\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-130a\/","url":"https:\/\/japanir.jp\/en\/company\/company-130a\/","name":"VERITAS IN SILICO INC - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-04T14:21:33+00:00","dateModified":"2026-07-26T05:54:50+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-130a\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-130a\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-130a\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"VERITAS IN SILICO INC"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/60783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=60783"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=60783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}